# Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

> **NCT01005654** · — · RECRUITING · sponsor: **National Cancer Institute (NCI)** · enrollment: 2415 (estimated)

## Conditions studied

- Endocrine Tumors
- Thyroid Neoplasms
- Parathyroid Neoplasms
- Adrenal Neoplasm
- Neuroblastoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01005654
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2009-10-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 2415 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01005654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01005654, "Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01005654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*